塞力医疗
This page follows insider dealings at Thalys Medical Technology Group Corporation as filed with SSE / SZSE (CSRC), a company from the Health Care sector. Nothing new has been filed by managers of Thalys Medical Technology Group Corporation in twelve months, the latest record being from 7 November 2022.
The full history, which starts in 2021, counts no purchases against 3 sales.
For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
塞力医疗 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and manufacturing of medical devices and innovative health solutions.